GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
PROM1 | 9454 | LTM | Skin Cancer | NA | D10 | NA | FACs followed by SFA and qRT-PCR | NA | 0.32 | 0.7582 | 26208390
|
KLF4 | 6348 | LTM | Skin Cancer | NA | D10 | NA | SFA and CFA followed by qRT-PCR | NA | 0.2 | 0.0891 | 26208390
|
NANOG | 20857 | LTM | Skin Cancer | NA | D10 | NA | SFA and CFA followed by qRT-PCR | NA | 0.2 | 0.5461 | 26208390
|
POU5F1 | 9221 | LTM | Skin Cancer | NA | D10 | NA | SFA and CFA followed by qRT-PCR | NA | 0.2 | 0.6448 | 26208390
|
SOX2 | 11195 | LTM | Skin Cancer | NA | D10 | NA | SFA and CFA followed by qRT-PCR | NA | 0.2 | 0.5695 | 26208390
|
ABCG2 | 74 | LTM | Skin Cancer | NA | D10 | NA | FACs followed by SFA | NA | 0.12 | 0.1739 | 26208390
|
CD44 | 1681 | LTM | Skin Cancer | NA | D10 | NA | FACs followed by SFA | NA | 0.12 | 1 | 26208390
|
MIR200C | 31580 | HTM | Skin Cancer | NA | D10 | NA | SFA and FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0074 | 26208390
|
MIR21 | 31586 | HTM | Skin Cancer | NA | D10 | NA | SFA and FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0085 | 26208390
|